Our cophenetic correlation coefficient calculations (CCC) are in support of EMMPRIN/CD147, CD99, Cathepsin D, Intβ1, ADAM9/-17, and Galectin-3 being suitable biomarkers for glioma cells and potentially, SLGCs. The gene discussed is ADAM9; the disease is central nervous system cancer.